日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

An IQ Consortium Perspective on the FDA Guidance for Assessment of Pharmacokinetics in Participants With Impaired Renal Function

IQ联盟对FDA关于肾功能受损患者药代动力学评估指南的看法

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.70190
Jin, Yan; Sharma, Ashish; Ahmed, Mariam A; Cheeti, Sravanthi; Ou, Ying; Devineni, Damayanthi; Chen, Yizhe; Kanodia, Jitendra S; Abouelhassan, Yasmeen; Noormohamed, Nadia; Zhou, Jin; Marroum, Patrick; Sahasrabudhe, Vaishali; Younis, Islam R
发表日期：2026
文献求助 收藏

Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors

基于生理药代动力学模型的卡利拉嗪与CYP3A抑制剂药物相互作用的标签标注

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70236
Riad, Md Mahbubul Huq; Marroum, Patrick; Shebley, Mohamad; Xiong, Hao
发表日期：2026
文献求助 收藏

Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development

基于模型的药物研发范式——以乌帕替尼研发为例的端到端案例研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70295
Bhatnagar, Sumit; Stodtmann, Sven; Qian, Yuli; Marroum, Patrick; Liu, Wei; Mohamed, Mohamed-Eslam F
发表日期：2025
文献求助 收藏

Assessment of Telisotuzumab Vedotin Drug-Drug Interaction Potential Using Physiologically-Based Pharmacokinetic Modeling and Simulations

利用基于生理的药代动力学模型和模拟评估泰利妥珠单抗维多汀的药物相互作用潜力

期刊:Journal of Clinical Pharmacology
影响因子:2.3
doi:10.1002/jcph.70108
Riad, Md Mahbubul Huq; Brunsdon, Priya; Menon, Rajeev; Marroum, Patrick; Parikh, Apurvasena
发表日期：2025
文献求助 收藏

Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet

对维奈托克低剂量片剂和口服粉剂制剂进行生物利用度评价，以确定其与 100 毫克片剂的互换性

期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-022-01172-4
Badawi, Mohamed; Chen, Xin; Marroum, Patrick; Suleiman, Ahmed A; Mensing, Sven; Koenigsdorfer, Anette; Schiele, Julia Teresa; Palenski, Tammy; Samineni, Divya; Hoffman, David; Menon, Rajeev; Salem, Ahmed Hamed
发表日期：2022
文献求助 收藏

Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposure

基于生理的药代动力学建模和模拟，可为溶出度指标和释放速率对依拉戈利暴露的临床意义提供信息。

期刊:Biopharmaceutics & Drug Disposition
影响因子:2
doi:10.1002/bdd.2315
Mukherjee, Dwaipayan; Chiney, Manoj S; Shao, Xi; Ju, Tzuchi R; Shebley, Mohamad; Marroum, Patrick
发表日期：2022
文献求助 收藏

Development of In Vitro-In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation

乌帕替尼缓释片剂体外-体内相关性研究

期刊:AAPS Journal
影响因子:3.7
doi:10.1208/s12248-019-0378-y
Mohamed, Mohamed-Eslam F; Trueman, Sheryl; Othman, Ahmed A; Han, Jian-Hwa; Ju, Tzuchi R; Marroum, Patrick
发表日期：2019
文献求助 收藏

Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse

利用临床药理学库加速儿科肿瘤药物研发

期刊:Journal of Clinical Pharmacology
影响因子:2.3
doi:10.1002/jcph.1359
Shebley, Mohamad; Menon, Rajeev M; Gibbs, John P; Dave, Nimita; Kim, Su Y; Marroum, Patrick J
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Drugs in psychology: A commentary on Travis Thompson and Charles R. Schuster's Behavioral Pharmacology

药物在心理学中的应用：对特拉维斯·汤普森和查尔斯·R·舒斯特的《行为药理学》的评论

期刊:AAPS Journal
影响因子:3.7
doi:10.1208/aapsj070351
Bhattaram, Venkatesh A; Booth, Brian P; Ramchandani, Roshni P; Beasley, B Nhi; Wang, Yaning; Tandon, Veneeta; Duan, John Z; Baweja, Raman K; Marroum, Patrick J; Uppoor, Ramana S; Rahman, Nam Atiqur; Sahajwalla, Chandrahas G; Powell, J Robert; Mehta, Mehul U; Gobburu, Jogarao V S; Dews, P B
发表日期：1970
文献求助 收藏